EC Orthopaedics

The global cost of chronic disease management is now estimated at over $5 trillion per year. That figure includes pharmaceuticals, hospitalisations, diagnostics, insurance administration, lost productivity, disability payments, and the downstream social costs that never appear in any health ministry budget but devastate every economy that carries them. It does not include the cost of the pharmaceutical waste stream, the antimicrobial resistance crisis it accelerates, or the environmental remediation that every government will eventually have to fund. Those costs are still accumulating and no one has seriously attempted to total them. None of that spending cures chronic disease. It manages it. It maintains it. In many cases, it extends it. The pharmaceutical model of medicine is not structured to eliminate the conditions it treats. It is structured to accompany them, for as long as the patient lives, at whatever price the market will bear. This is not a conspiracy. It is an economic structure. The incentive of every pharmaceutical intervention for chronic disease is the same: keep the patient on the prescription. A cured patient is a lost customer. That is not rhetoric. It is the business model. What Professor Andrew Hague understood, decades before anyone else was willing to say it plainly, is that this structure cannot be reformed. It can only be replaced. Not with better drugs. Not with cheaper drugs. Not with greener drugs. With infrastructure that makes drugs unnecessary for the conditions they were never designed to cure. That infrastructure is Sapiens Shield.

What chronic disease actually costs

The numbers are public. They are published by the organisations that have the least incentive to exaggerate them, because every figure is an admission of failure.

 The World Health Organization estimates that noncommunicable diseases, the bureaucratic term for chronic disease, kill 41 million people every year. That is 74 percent of all deaths globally. Cardiovascular disease, cancer, chronic respiratory conditions, and diabetes alone account for over 80 percent of those deaths. The majority of them are preventable. The WHO itself says so. Then it asks for more funding for the same interventions that have been failing to prevent them for the last fifty years [1].

 In the United States alone, the Centers for Disease Control estimates that 90 percent of the nation's $4.5 trillion in annual healthcare expenditure goes to chronic and mental health conditions. Ninety percent. Six in ten American adults have at least one chronic disease. Four in ten have two or more. The system designed to treat them has produced the most expensive healthcare on earth and some of the worst chronic disease outcomes in the developed world [2].

 In the United Kingdom, the National Health Service spends approximately 70 percent of its budget on chronic conditions. The NHS is perpetually in crisis. It is not in crisis because it lacks funding. It is in crisis because it is structured to manage conditions that compound over time, in a population that is aging, in a model that generates more cost with every year of management and never produces a resolution.

 Every country tells the same story. The details change. The structure does not. Chronic disease is the single largest economic burden on every healthcare system on earth, and the systems designed to address it are incapable of reducing that burden because they are the burden.

 The fact that changes everything

A healthy human cell maintains an electrical charge across its membrane of approximately minus 70 to minus 75 millivolts. This is not alternative medicine. This is documented in NASA technical papers from 1970, in peer-reviewed research from the Karolinska Institute in 1983, in the published work of Dr. Steve Haltiwanger, and in the National Institutes of Health's own literature on membrane potential and disease progression [7-9].

 When that voltage drops, the cell loses function. At minus 50 millivolts, a person is chronically fatigued. At minus 15 millivolts, the cell switches from aerobic respiration to fermentation, the metabolic signature of cancer. At minus 10 millivolts, the cell replicates without control. That is not a theory of cancer. It is a measurement of cancer. It has been measured independently by scientists on three continents across nine decades, none of whom were aware of each other's work when they reached the same conclusion.

 In February 2026, the United States Food and Drug Administration approved an electric field cancer treatment for the fourth time. The device, made by Novocure, applies a low-level alternating electrical field to the body for 18 hours a day over months. The FDA's own documentation, and the peer-reviewed literature surrounding the approval, states plainly that the precise mechanism is not fully understood. The FDA approved it anyway because the clinical results were undeniable [10,11].

 That approval demolished the last institutional objection to electrical medicine. For a century, the objection was that the mechanism was unproven. The FDA just approved a device whose own researchers say the mechanism is not fully understood. Results were enough. The argument is over.

 CellSonic has understood the mechanism for 37 years. Professor Hague did not need the FDA to validate what the physics already proved. But now that the FDA has, the conversation shifts from whether electrical medicine works to who can deliver it at population scale.

What Sapiens Shield actually is

Sapiens Shield is not a product. It is not a treatment protocol. It is not a clinic. It is a population-scale infrastructure programme that eliminates chronic disease as a category of human suffering and economic cost. It does this by finding disease before the patient knows it exists, correcting it in minutes, and addressing the cause so it does not return.

 The programme has three stages, all of which happen in a single visit.

 Stage one is diagnosis and treatment. A CellSonic operator checks the patient from head to toe. The technology reads the electrical state of the body's cells. Where voltage has dropped, the condition is identified. Where a cluster of cells has begun replicating at low voltage, cancer is found, often years before any scan or blood test would detect it. The CellSonic VIPP machine then corrects the voltage. It fires a 25,000-volt nanosecond electromagnetic burst paired with a pressure wave. The pulse lasts a billionth of a second. The cell voltage is restored from minus 15 millivolts to minus 75 millivolts. The treatment takes under two minutes. No drugs are introduced. No chemicals enter the body. Nothing is left behind for the kidneys to filter, the wastewater system to fail to remove, or the rivers to carry into the drinking supply. The treatment is over when the machine turns off.

 This entire process, diagnosis and correction, takes 20 minutes per person. Three patients per hour. Operating six days a week, one clinic handles a population of 8,000 people with checks twice a year. That is the arithmetic. It does not require a spreadsheet. It requires a building, a machine, a trained operator, and a population that wants to live.

 Stage two is where Sapiens Shield does what no healthcare system on earth has ever attempted. Every cancer case CellSonic has treated, when the full story comes out, was caused by prolonged stress that disabled the immune system long enough for the tumours to grow. The stress is almost always relational. A dysfunctional family. An abusive marriage. A child who has never known safety. A worker trapped in conditions they cannot escape. The voltage can be corrected in two minutes. If the cause of the voltage drop is still operating on the patient, the voltage will fall again. CellSonic operators have heard this described so many times it has its own language now. The cancer is switched off by the machine and switched back on by the life the patient returns to.

 So, the patient moves to a second room. In that room sits a person Professor Hague calls the granny. An older person, usually a woman, who has seen life in all its difficulty and still smiles. Someone who listens. Someone with the intuition to know that the person sitting in front of them is carrying something they have never been able to tell anyone. The patient talks. They want to talk. The problem has never been that these people have nothing to say. The problem is that no one in their life has ever listened. The granny listens. The conversation takes an hour, sometimes more. It is never rushed. It identifies not just the stress but the social and economic conditions producing the stress. And then support is offered. Real support.

 Community support. Not a prescription. Not a referral to a six-month waiting list. A human being offering to help another human being stay alive.

 Stage three is the consequence that no government has yet understood but every government will. The person whose cancer was found and corrected before they knew they had it, whose stress was identified and addressed before it destroyed their family, is also the person who was on the path to economic collapse, domestic violence, substance abuse, or crime. Not because they were a bad person. Because they were a broken person in a system that does not fix people. It medicates them, polices them, imprisons them, and pays for all of it forever. Sapiens Shield finds the fracture before it becomes a break. It addresses health, social cohesion, and economic stability in a single visit because they are not three separate problems. They are one problem expressing itself in three ways.

 No one is born a criminal. Prisons and the police are useless because they do not find the problem until after the crime and they do not rehabilitate. Sapiens Shield finds the problem.

The arithmetic that makes this inevitable

One CellSonic machine costs less than one year of one cancer patient on Novocure's treatment at $27,000 per month. Once a clinic owns the machine, it treats every patient who walks through the door. The consumable cost is the shock head, which generates recurring revenue for CellSonic and costs the clinic a fraction of any pharmaceutical intervention for the same condition. The machine does not expire. It does not require a cold chain. It does not require the packaging, distribution, storage, and disposal infrastructure that pharmaceutical delivery demands.

 One clinic serves 8,000 people. A country of 40 million needs 5,000 clinics. A world of 8 billion needs one million. That sounds like a large number until you compare it to the 340,000 pharmacies in the United States alone, or the millions of pharmaceutical distribution points worldwide, each of which must be continuously resupplied with products that expire, require temperature control, and produce a waste stream that contaminates the water supply of the population they were prescribed to help.

 The cost of building Sapiens Shield infrastructure at national scale is a fraction of one year's chronic disease expenditure in any country that builds it. In the United States, where chronic disease consumes $4 trillion annually, the entire Sapiens Shield infrastructure for the country would cost less than what the system currently spends in a single quarter. In any developing nation, the comparison is even more decisive, because the pharmaceutical infrastructure those countries are being asked to build has not yet been built. They can skip it entirely. They can build the infrastructure that works instead of the infrastructure that manages failure.

 The environmental arithmetic is equally decisive. Every pharmaceutical dose prescribed anywhere on earth ends up somewhere. The University of York's 2022 study of 258 rivers across 104 countries found pharmaceutical contamination on every continent. Metformin, the most widely prescribed diabetes drug on earth, was detected in 89 percent of stream samples in the southeastern United States alone. These residues act as endocrine disruptors in aquatic organisms. They select for antimicrobial resistance in [3,16] bacterial populations. The Lancet's 2022 global burden analysis found that antimicrobial resistance was directly responsible for 1.27 million deaths in 2019 and associated with 4.95 million. By 2050, those numbers are projected to reach 1.91 million and 8.22 million respectively [4,5].

 CellSonic produces no metabolite. No excreted residue. No downstream contamination. A device that treats ten thousand patients produces the same environmental burden as a device that treats one: zero. That is not a marginal improvement over pharmaceutical medicine. It is a categorically different relationship with the environment. The countries that build Sapiens Shield will not need to build the pharmaceutical waste remediation infrastructure that the countries relying on drugs will eventually be forced to fund.

Why the establishment cannot build this

The pharmaceutical model of chronic disease management generates approximately $1.4 trillion in global revenue per year. That revenue depends on patients remaining in treatment. Every cure is a commercial loss. Every prevented disease is a customer who never existed. The structure of the industry is not aligned with the elimination of chronic disease. It is aligned with the perpetuation of chronic disease at the highest sustainable price.

 This is not an accusation. It is an observation about incentives. The pharmaceutical industry employs millions of people, funds the majority of medical education, sponsors the conferences where treatment guidelines are written, and contributes to the campaigns of the politicians who regulate it. That structure cannot reform itself any more than the horse-drawn carriage industry could have invented the automobile. The replacement comes from outside. It always does.

 Medical education compounds the problem. Entry to medical school selects for the ability to memorise, not the ability to listen. The curriculum is structured around surgery and pharmacology. Biophysics is not taught. Empathy is not assessed. Graduates emerge believing that medicine is biochemistry and everything else is quackery, despite the fact that every hospital in every country uses lithotripsy, a biophysics technology, to treat kidney stones without drugs. Millions of patients over forty years. No side effects. The same physics that CellSonic applies to chronic disease. The establishment uses biophysics when it has no pharmaceutical alternative and refuses to see it when it does.

 The regulatory environment reflects the same bias. Clinical trials were designed for pharmaceuticals. They exist to measure side effects, because pharmaceuticals always have side effects. When a biophysics technology with no side effects applies for approval, it faces the same trial requirements designed for chemicals that poison healthy cells alongside diseased ones. The trial process costs hundreds of millions of dollars and takes decades. Novocure spent 25 years and four FDA approvals reaching $655 million in annual revenue and still cannot turn a profit. Only 4,620 patients are on therapy worldwide. That is what the approved route produces. CellSonic chose a different path because the approved path is designed to protect the model it would replace [10].

What happens in year one

After one year of Sapiens Shield operating in a town of 8,000 people, that town reports no new chronic disease cases that progressed beyond early detection. No cancer that grew to the point of symptoms. No diabetes that reached the point of pharmaceutical dependency. No cardiovascular condition that required hospitalisation. For the first time in the recorded history of any population on earth.

 The data is recorded on a distributed blockchain. Every treatment: the patient identifier, the condition, the voltage state before and after, the number of sessions, and the outcome. Once written, the record cannot be altered. Not by the clinic. Not by CellSonic. Not by any government, pharmaceutical company, or institution that has historically been able to suppress the evidence for electrical medicine. The data is permanent. The evidence is sovereign.

 This matters because of history. Royal Rife demonstrated electrical cancer treatment to 44 physicians in 1934. His laboratory was destroyed by fire in 1946. His records were lost. Bjorn Nordenstrom, former Chairman of the Nobel Prize Assembly for Medicine, documented the electrical treatment of cancer across 20,000 patients in China with Ministry of Public Health approval. His work was largely ignored by Western oncology. The pattern across nine decades of independent electrical medicine research is consistent: evidence held in a single location can be seized, destroyed, or discredited. Sapiens Shield removes that vulnerability permanently [8,15].

 The news from that first town does not need a journal to carry it. People tell people. Every family knows someone in another country. The smartphones that are permanently glued to every hand carry the message faster than any publication. The news is true because it came from a reliable source: a friend, a relative, someone who was there. It is good news. The media rarely carries good news, so it spreads through the networks that people actually trust. Eventually the investigators arrive looking for the scam. Their investigation leads back to the clinic. The scam turns out to be the one they never investigated: a century of suppressing the science that would have ended the need for the products they were paid to advertise.

The infrastructure investment

Sapiens Shield is infrastructure in the same category as roads, power grids, and water treatment systems. It is built once. It operates continuously. It eliminates a category of cost that would otherwise grow every year forever. No government that builds a road expects to keep building the same road every year. No government that installs a power grid expects to install it again next decade. But every government that funds a pharmaceutical healthcare system expects to fund it again next year, at a higher cost, for a larger population, with worse outcomes for chronic disease. That is not infrastructure. That is a subscription to failure.

 The capital required to build Sapiens Shield at national scale in any country on earth is less than what that country currently spends on chronic disease management in a single year. In most countries, it is less than what they spend in a single quarter. The return is not gradual. It is immediate. Every person checked and corrected is a person who does not develop the condition that would have cost the system tens or hundreds of thousands of dollars over their remaining lifetime. Every cancer found at stage zero and corrected in two minutes is a cancer that never reaches the stage where it costs $200,000 a year in chemotherapy, radiation, surgery, and hospice care for five years before the patient dies anyway. Every family stabilised by the intervention of a compassionate listener is a family that does not produce the domestic violence case, the substance abuse case, the criminal case, or the mental health crisis that the justice and social services systems will otherwise pay for indefinitely.

 The compounding effect is what makes this a $2 billion investment proposition rather than a medical curiosity. Every machine sold generates recurring shock head revenue. Every clinic that operates generates referrals from the population it serves. Every town that reports no new chronic disease cases generates demand from the next town, the next region, the next country. The evidence is on a blockchain that cannot be suppressed. The economics are transparent. The technology is certified, operating, and documented across 60 peer-reviewed publications and 30 case reports.

 Professor Hague built the technology. He understood the mechanism before anyone else. He treated the first cancer patient in 2016. He saw what no medical school teaches and no pharmaceutical company will fund: that the body is an electrical system, that disease is an electrical fault, and that the correction is electrical, not chemical. What he built is not a product. It is the foundation of the last infrastructure any healthcare system will ever need to build [12,15].

 The species-level view

Homo Sapiens is 80,000 years old. For 79,900 of those years, the species survived without pharmaceutical medicine. It survived because its body contains three systems that maintain health when they are functioning correctly: the microbiome, which converts food into useable energy; the immune system, which detects and repairs cellular faults every night during sleep; and the mind, which governs the other two through the state of mind that either supports or undermines them.

 Modern life disrupts all three. Industrial food undermines the microbiome. Sedentary existence deprives the immune system of the physical demands it evolved to support. Chronic stress, almost always relational, almost always rooted in family dysfunction passed down through generations, disables the mind's ability to maintain the other two systems. The pharmaceutical model responds to the symptoms of that disruption. It never addresses the disruption itself. It cannot, because addressing the disruption would eliminate the need for the products.

 Sapiens Shield addresses all three systems in a single programme. The voltage correction restores the electrical conditions the immune system needs to function. The diagnostic check identifies microbiome disruption through its electrical signature. The granny addresses the mind, the controller that was never going to be reached by a prescription.

 This is what Andrew Hague saw that the medical establishment has spent a century refusing to see. The three systems are interlinked. If one fails, the other two follow. No pharmaceutical intervention addresses all three because no pharmaceutical can. A chemical that enters the body can interact with the microbiome. It cannot repair the immune system's electrical function. It cannot resolve the relational stress that disabled the mind. Only a programme that treats the person as an integrated electrical and social being can address all three. That programme is Sapiens Shield.

What this document is asking for

This document is not asking for belief. The physics is documented. The clinical evidence is published. The FDA has validated the category. The environmental argument is measured in 258 rivers across 104 countries. The economic argument is published in the budget of every health ministry on earth.

This document is asking for capital to build the infrastructure that replaces the most expensive, most wasteful, most environmentally destructive, and least effective component of every healthcare system in the world. The technology is complete. The protocol is tested. The evidence architecture is designed. What does not yet exist at scale is the network of clinics that brings this to every population on earth.

The vehicle is built. It has been road-tested for years. What it has never had is a full tank.

1. World Health Organization. “Noncommunicable diseases: key facts”. WHO, updated (2023).
2. Centers for Disease Control and Prevention. Chronic Diseases in America. CDC National Center for Chronic Disease Prevention and Health Promotion.
3. Wilkinson JL., et al. “Pharmaceutical pollution of the world's rivers”. Proceedings of the National Academy of Sciences8 (2022): e2113947119.
4. Murray CJL., et al. “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis”. The Lancet10325 (2022): 629-655.
5. GBD 2021 Antimicrobial Resistance Collaborators. “Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050”. The Lancet10459 (2024): 1199-1226.
6. He Y., et al. “Metformin contamination in global waters”. Environmental Science and Technology 19 (2022): 13528-13545.
7. Cone CD Jr. “Combined adenosine triphosphate and membrane potential control of cell division”. NASA Technical Paper NTRS 19700019348 (1970).
8. Nordenstrom BEW. “Biologically closed electric circuits: clinical, experimental and theoretical evidence for an additional circulatory system”. Nordic Medical Publications, Stockholm (1983).
9. Haltiwanger S. “The electrical properties of cancer cells” (2010).
10. Q4 and Full Year 2025 Financial Results. Published February 26, 2026.
11. Expert Review of Molecular Diagnostics, 2022. TTFields mechanism stated as not fully understood.
12. Hague A. “Sapiens Shield: CellSonic cures chronic disease in a person, Sapiens Shield stops chronic disease in a population”. Journal of Endocrine System and Diabetes (2022).
13. Busch C., et al. “Total Resolution of a Stage 4 Refractory Diabetic Ulcer Using CellSonic VIPP”. Cell Physiology and Biochemistry (2017).
14. Halls G PhD. The architectural betrayal: A review of systematic biological failure induced by conventional oncology. Independent Literature Review (2025).
15. Hague A. “Cancer cure: The protocol and explanation”. Journal of Cancer and Oncology Research (2020).
16. Bradley PM., et al. “Metformin and other pharmaceuticals widespread in wadeable streams of the southeastern United States”. Environmental Science S Technology Letters6 (2016): 243-249.